Effect of a novel long-acting interleukin-7 agonist, NT-I7, on survival in mouse models of glioma.

e13516Background: Glioblastoma is one of the most devastating cancers, with a 5-year overall survival < 10%. Patients are routinely treated with radiation therapy (RT) and temozolomide (TMZ). These...